Researchers announce the creation of Wisconsin’s very first Alzheimer’s Disease Research Center (W-ADRC). The Wisconsin ADRC is funded by a grant from the National Institute on Aging (NIA) and the National Institute of Health (NIH). The Wisconsin ADRC will be a research facility based out of the UW-Madison’s Department of Geriatrics in the School of Medicine and Public Health, and the Wm. S. Middleton Memorial Veterans Hospital. The Wisconsin ADRC was the only new facility to be recognized by the NIH with this award for the funding year of 2009.
This grant award will further fund the research of the Wisconsin Comprehensive Memory Program’s (WCMP) former efforts in areas of Alzheimer’s disease treatment and prevention research. The major focus of the Wisconsin ADRC is on preclinical and early diagnosis and progression of AD. It will expand the scientific objectives of the NIH-funded Wisconsin Registry for Alzheimer’s Prevention (WRAP), significantly enhancing care of Wisconsin residents suffering from the devastations of AD.
The major focus of the Wisconsin ADRC, and perhaps the most important characteristic of this Center, is to identify novel diagnostic tests and potential therapies for the prevention of AD at a stage when patients have no clinical symptoms (preclinical stage). It is anticipated that such therapies will help reduce the burgeoning number of individuals projected to suffer from AD.
While most function Centers are based in the fields of neurology and psychology, this is the first time in NIH history that a geriatrics-based ADRC has been funded. The Wisconsin ADRC will build upon the remarkable strengths of the University of Wisconsin and the work of the Wisconsin Comprehensive Memory Program to provide state-of-the-art resources, infrastructure, and expertise in Alzheimer’s disease (AD) and related illnesses.